Market Overview

UPDATE: Barrington Reiterates Outperform Rating, $650 PT on Intuitive Surgical

Related ISRG
FDA Clears da Vinci(R) System Use in Benign Base of Tongue Resection Procedures
Wedbush Sees 'Stabilized' Market For Intuitive Surgical, Inc.
Stocks Sell Off as Shift from Risk Persists (Fox Business)

In a report published Friday, Barrington reiterated its Outperform rating and $650.00 price target on Intuitive Surgical (NASDAQ: ISRG).

Barrington noted, “We are reiterating our OUTPERFORM rating and $650 price target following ISRG's Q4/12 earnings as we believe management will continue to execute on its significant market opportunities over the short and long term and will drive strong procedure growth/pricing power with new technologies in new procedures. We believe the short reports circulated recently are largely based on unfounded concerns and we expect the patient and hospital demand for da Vinci procedures to remain high in the face of the issues highlighted in those reports.”

Intuitive Surgical closed on Thursday at $576.07.

Latest Ratings for ISRG

DateFirmActionFromTo
Sep 2014RBC CapitalInitiates Coverage onSector Perform
Jul 2014Raymond JamesUpgradesMarket PerformOutperform
Jul 2014Stifel NicolausUpgradesHoldBuy

View More Analyst Ratings for ISRG
View the Latest Analyst Ratings

Posted-In: BarringtonAnalyst Color Reiteration Analyst Ratings

 

Related Articles (ISRG)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters

Benzinga Professional